161 related articles for article (PubMed ID: 22376252)
21. Effects of aging and atherosclerosis on endothelial and vascular smooth muscle function in humans.
Al-Shaer MH; Choueiri NE; Correia ML; Sinkey CA; Barenz TA; Haynes WG
Int J Cardiol; 2006 May; 109(2):201-6. PubMed ID: 16054252
[TBL] [Abstract][Full Text] [Related]
22. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.
Gilligan DM; Panza JA; Kilcoyne CM; Waclawiw MA; Casino PR; Quyyumi AA
Circulation; 1994 Dec; 90(6):2853-8. PubMed ID: 7994830
[TBL] [Abstract][Full Text] [Related]
23. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.
Schlaich MP; Ahlers BA; Parnell MM; Kaye DM
J Hypertens; 2004 Oct; 22(10):1917-25. PubMed ID: 15361763
[TBL] [Abstract][Full Text] [Related]
24. Effect of anti-oxidant treatment and cholesterol lowering on resting arterial tone, metabolic vasodilation and endothelial function in the human forearm: a randomized, placebo-controlled study.
Duffy SJ; O'Brien RC; New G; Harper RW; Meredith IT
Clin Exp Pharmacol Physiol; 2001; 28(5-6):409-18. PubMed ID: 11380515
[TBL] [Abstract][Full Text] [Related]
25. High-density lipoprotein restores endothelial function in hypercholesterolemic men.
Spieker LE; Sudano I; Hürlimann D; Lerch PG; Lang MG; Binggeli C; Corti R; Ruschitzka F; Lüscher TF; Noll G
Circulation; 2002 Mar; 105(12):1399-402. PubMed ID: 11914243
[TBL] [Abstract][Full Text] [Related]
26. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Favilla S; Pompella A; Salvetti A
Hypertension; 2001 Mar; 37(3):943-8. PubMed ID: 11244022
[TBL] [Abstract][Full Text] [Related]
27. Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes.
Skyrme-Jones RA; O'Brien RC; Luo M; Meredith IT
J Am Coll Cardiol; 2000 Feb; 35(2):292-9. PubMed ID: 10676672
[TBL] [Abstract][Full Text] [Related]
28. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.
Taddei S; Virdis A; Mattei P; Natali A; Ferrannini E; Salvetti A
Circulation; 1995 Nov; 92(10):2911-8. PubMed ID: 7586259
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in salt sensitivity to nitric oxide dependent vasodilation in healthy young adults.
Eisenach JH; Gullixson LR; Kost SL; Joyner MJ; Turner ST; Nicholson WT
J Appl Physiol (1985); 2012 Mar; 112(6):1049-53. PubMed ID: 22194324
[TBL] [Abstract][Full Text] [Related]
30. Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium-derived nitric oxide and endothelial progenitor cells.
Kimura M; Ueda K; Goto C; Jitsuiki D; Nishioka K; Umemura T; Noma K; Yoshizumi M; Chayama K; Higashi Y
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1403-10. PubMed ID: 17446439
[TBL] [Abstract][Full Text] [Related]
31. Tetrahydrobiopterin improves impaired endothelium-dependent forearm vasodilation in patients with heart failure.
Setoguchi S; Hirooka Y; Eshima K; Shimokawa H; Takeshita A
J Cardiovasc Pharmacol; 2002 Mar; 39(3):363-8. PubMed ID: 11862115
[TBL] [Abstract][Full Text] [Related]
32. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age.
Lyons D; Roy S; Patel M; Benjamin N; Swift CG
Clin Sci (Lond); 1997 Dec; 93(6):519-25. PubMed ID: 9497788
[TBL] [Abstract][Full Text] [Related]
33. Divergent nitric oxide bioavailability in men and women with sickle cell disease.
Gladwin MT; Schechter AN; Ognibene FP; Coles WA; Reiter CD; Schenke WH; Csako G; Waclawiw MA; Panza JA; Cannon RO
Circulation; 2003 Jan; 107(2):271-8. PubMed ID: 12538427
[TBL] [Abstract][Full Text] [Related]
34. Enhanced vasodilation to acetylcholine in athletes is associated with lower plasma cholesterol.
Kingwell BA; Tran B; Cameron JD; Jennings GL; Dart AM
Am J Physiol; 1996 Jun; 270(6 Pt 2):H2008-13. PubMed ID: 8764251
[TBL] [Abstract][Full Text] [Related]
35. Endothelium-derived hyperpolarizing factor contributes to hypoxia-induced skeletal muscle vasodilation in humans.
Spilk S; Herr MD; Sinoway LI; Leuenberger UA
Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1639-45. PubMed ID: 24043253
[TBL] [Abstract][Full Text] [Related]
36. Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease.
Ozkor MA; Murrow JR; Rahman AM; Kavtaradze N; Lin J; Manatunga A; Quyyumi AA
Circulation; 2011 May; 123(20):2244-53. PubMed ID: 21555712
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients.
Giannarelli C; De Negri F; Virdis A; Ghiadoni L; Cipriano A; Magagna A; Taddei S; Salvetti A
Hypertension; 2007 Apr; 49(4):878-84. PubMed ID: 17339540
[TBL] [Abstract][Full Text] [Related]
38. Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.
Pretorius M; Brown NJ
J Pharmacol Exp Ther; 2010 Jan; 332(1):291-7. PubMed ID: 19841473
[TBL] [Abstract][Full Text] [Related]
39. Altered nitric oxide bioavailability contributes to diesel exhaust inhalation-induced cardiovascular dysfunction in man.
Langrish JP; Unosson J; Bosson J; Barath S; Muala A; Blackwell S; Söderberg S; Pourazar J; Megson IL; Treweeke A; Sandström T; Newby DE; Blomberg A; Mills NL
J Am Heart Assoc; 2013 Feb; 2(1):e004309. PubMed ID: 23525434
[TBL] [Abstract][Full Text] [Related]
40. Selective loss of microvascular endothelial function in human hypercholesterolemia.
Gilligan DM; Guetta V; Panza JA; García CE; Quyyumi AA; Cannon RO
Circulation; 1994 Jul; 90(1):35-41. PubMed ID: 8026018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
